Skip to Main Content

Author Details

Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
1991
231
93
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36409824JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.Cancer Res2023
36409824JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.Cancer Res2023
37676980Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.Mol Cancer Ther2023
38011567Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression.Proc Natl Acad Sci U S A2023
37863030HATS off to KAT6A/B inhibitors: A new way to target estrogen-receptor-positive breast cancer.Cell Chem Biol2023
37322009A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer.Nat Commun2023
37001528Challenges and opportunities for modeling aging and cancer.Cancer Cell2023
37248149Clinical and translational relevance of intratumor heterogeneity.Trends Cancer2023
37433282Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.Cancer Cell2023
37048158Copy Number Variation in Inflammatory Breast Cancer.Cells2023
37863030HATS off to KAT6A/B inhibitors: A new way to target estrogen-receptor-positive breast cancer.Cell Chem Biol2023
38011567Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression.Proc Natl Acad Sci U S A2023
37676980Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.Mol Cancer Ther2023
37322009A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer.Nat Commun2023
37048158Copy Number Variation in Inflammatory Breast Cancer.Cells2023
37248149Clinical and translational relevance of intratumor heterogeneity.Trends Cancer2023
37001528Challenges and opportunities for modeling aging and cancer.Cancer Cell2023
37433282Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.Cancer Cell2023
34933050A Darwinian perspective on tumor immune evasion.Biochim Biophys Acta Rev Cancer2022
35700706Bacterial Darth Vader: May the force be with you.Cancer Cell2022
35446942Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer.Cancer Immunol Res2022
35941364Untangling the web of intratumour heterogeneity.Nat Cell Biol2022
35417004Report of the First International Symposium on NUT Carcinoma.Clin Cancer Res2022
36400020Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.Cancer Cell2022
36476730Breast cancer prevention by short-term inhibition of TGFβ signaling.Nat Commun2022
35031563Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.Proc Natl Acad Sci U S A2022
34933050A Darwinian perspective on tumor immune evasion.Biochim Biophys Acta Rev Cancer2022
35700706Bacterial Darth Vader: May the force be with you.Cancer Cell2022
35417004Report of the First International Symposium on NUT Carcinoma.Clin Cancer Res2022
35446942Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer.Cancer Immunol Res2022
36476730Breast cancer prevention by short-term inhibition of TGFβ signaling.Nat Commun2022
36400020Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.Cancer Cell2022
35941364Untangling the web of intratumour heterogeneity.Nat Cell Biol2022
35031563Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.Proc Natl Acad Sci U S A2022
33443130Genomic Alterations during the <i>In Situ</i> to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System.Mol Cancer Res2021
33897809Identifying key questions in the ecology and evolution of cancer.Evol Appl2021
33941592Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.Cancer Discov2021
33886505The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.JCI Insight2021
33443130Genomic Alterations during the <i>In Situ</i> to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System.Mol Cancer Res2021
34400468The MCF10 Model of Breast Tumor Progression.Cancer Res2021
33897809Identifying key questions in the ecology and evolution of cancer.Evol Appl2021
33886505The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.JCI Insight2021
34400468The MCF10 Model of Breast Tumor Progression.Cancer Res2021
33941592Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.Cancer Discov2021
32289271Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.Cancer Cell2020
32238387Immune Escape during Breast Tumor Progression.Cancer Immunol Res2020
32289271Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.Cancer Cell2020
32393766Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer.Nat Commun2020
32277005Premenopausal Plasma Osteoprotegerin and Breast Cancer Risk: A Case-Control Analysis Nested within the Nurses' Health Study II.Cancer Epidemiol Biomarkers Prev2020
32704543Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition.Sci Adv2020
  • 1 - 50 of 462

Recommended Authors

Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 25
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 7
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 15
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 6
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 4
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 15
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 19
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 29
Alejandra Bruna
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2002
Number of shared co-authors 11
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 1
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 0
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 2
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 4
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 6
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 14
Hal K Berman
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 2
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 8
Michael T Lewis
Baylor College of Medicine
Career Start Year 1996
Number of shared co-authors 11
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 4
Alexander D Borowsky
University of California Davis Health
Career Start Year 1995
Number of shared co-authors 7
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 0
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 2
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 28
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 15
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 30
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 24
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 25

Collaborators

Andrea L Richardson
Co-authored papers 19
Jun Yao
The University of Texas MD Anderson Cancer Center
Co-authored papers 18
Kenneth W Kinzler
Co-authored papers 14
Bert Vogelstein
Co-authored papers 14
Yuri Nikolsky
Co-authored papers 12
Judy E Garber
Dana-Farber Cancer Institute
Co-authored papers 11
Ian E Krop
Co-authored papers 11
Pedram Argani
The Johns Hopkins Hospital
Co-authored papers 11
Myles Brown
Co-authored papers 10
Tatiana Nikolskaya
Co-authored papers 10
Muhammad B Ekram
Louisiana State University
Co-authored papers 9
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 8
Xiaole Shirley Liu
Co-authored papers 8
Victor E Velculescu
Co-authored papers 7
Marina Bessarabova
Thomson Reuters Scientific Inc.
Co-authored papers 7
James M Roberts
Fred Hutchinson Cancer Research Center
Co-authored papers 6
Gregory J Riggins
Co-authored papers 5
Mithat Gonen
Co-authored papers 5
Rameen Beroukhim
Co-authored papers 5
Tari A King
Co-authored papers 5
Ian G Campbell
Co-authored papers 5
Simona Cristea
Dana-Farber Cancer Institute
Co-authored papers 5
Matthew Meyerson
Broad Institute
Co-authored papers 4
Jean J Zhao
Co-authored papers 4
Eric P Winer
Dana-Farber Cancer Institute
Co-authored papers 4
Alexander Meissner
Co-authored papers 4
Li Cai
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Donald C Allred
Co-authored papers 4
Phillip Buckhaults
University of South Carolina
Co-authored papers 4
Dennis C Sgroi
Co-authored papers 4
Release 1.2